AlmenT: Development of Nonionic Contrast Media. Invest Radiol. 20 (Suppl. 1) January/February 1985.
2.
BonnemainB: Sludge and low-osmolar contrast agents. A recent developement with potential clinical consequences. Contras Media 87, World Symposium, May 25–29, 1987. Montbazon, France (soumis à publication in Acta Radiol.).
3.
BrennanRERapoportS: CT-determined canine kidney and urine iodine concentrations following intravenous administration of Sodium Diatrizoate, Metrizamide, Iopamidol and Sodium Ioxaglate. Invest Radiol17: 95–100, 1982.
BuchmanASKlawansHLRusselEJ: Review: metrizamide and its neurologic complications. Clin Neuropharmacol10: 1–25, 1987.
6.
CahnJBorziexMGCahnR: Etude expérimentale comparée de la tolérance du systéme nerveux central à l'administration d'Iopamidol, de Metrizamide, d'Ioxitalamate, d'Ioxaglaté et d'Iocarmate. Ann Radiol26: 774–778, 1983.
7.
CailléJMGuibert-TrainerF: Contamination encéphalique par le métrizamide après myélographie. Neuroradiology7: 3–12, 1980.
8.
CailléJMGiouxM: Neurotoxicity of nonionic iodinated water-soluble contrast media in myelography: experimental study. AJNR4: 1185–1189, 1983.
9.
CaillèJMBidabéAMGuibert-TrainerF: Injection intraveineuse d'Iopamidol: Utilisation tomodensitométrique dans l'encéphale. Ann Radiol26: 801–806, 1983.
10.
CastelJCDorcierFCailléJM: Penetration of the brain by nonionic water soluble tri-and hexaiodinated contrast media. Neuroradiology29: 206–210, 1987.
11.
CittadiniGGarlarschiG: Silvestri E: Some operational aspects about the pharmacokinetics of uroangiographic iodinated contrast media. Radiol Med72 (Suppl. 2): 25–28, 1986.
12.
DawsonP: Chemotoxicity of contrast media and clinical adverse effects: A review. Invest Radiol20 (Suppl. 1) January/February 1985.
13.
DawsonPHarrisonMJGWeisblattE: Effect of contrast media on red cell filtrability and morphology. Brit J Radiol56: 707, 1983.
14.
DawsonPHeronCMarshallJ: Intravenous urography with low-osmolality contrast agents: Theoretical considerations and clinical findings. Clin Radiol35: 173–175, 1984.
15.
DeanPBKivisaariKormano M: Contrast enhancement pharmacokinetics of six ionic nonionic contrast media. Invest Radiol18: 368–374, 1983.
16.
DeanPB: Optimal contrast media for CT: Ionic or nonionic, monomer or dimer? In: Contrast Media in Radiology. AmielM, Springer Verlag, Heidelberg, 1982; 307–310.
17.
DorwartRHLamastersDLWatanabeTJ: Tumors. In: Modern Neuroradiology. Vol. 1. Computed tomography of the spine and spinal cord. Ed. NewtonTH and PottsDG. Clavadel Press, San Anselmo, CA, 1983; 115–147.
18.
DuboisPJDraverBP: Intramedullary penetrance of metrizamide in the dog spinal cord. AJN2: 313–317, 1981.
19.
Du BoulayGH: Theoretical considerations and pratical use of contrast agents other than iodine in CT. In: Computerized Tomography, CailléJM and SalamonG, Springer Verlag, Heidelberg, 1980; 172–178.
20.
DuchinMLDrayerBP: Pharmacokinetics of Iopamidol after intrathecal administration in humans. AJNR7: 895–896, 1986.
21.
FreyriaAMPinetA: Effects of five different contrast agents on serum complement and calcium levels after excretory urography. J Allergy Clin Immunol69: 397–403, 1982.
22.
GaleMERobbinsAH: Renal toxicity of contrast agents: Iopamidol, Iothalamate and Diatrozoate. AJR142: 333–335, 1984.
23.
GardeurDLautrouJ: Pharmacokinetics of contrast media: experimental results in dog and man with CT implications. J Comput Assist Tomogr: 178–185, 1980.
24.
GonsetteRE: The neurotoxicity of water-soluble contrast media: actual concepts and future. In: Contrast Media in Radiology, AmielM Ed, Springer-Verlag, Berlin, Heidelberg, New York, 1982; 115–122.
25.
HershkowitzNBryanN: Neurotoxic effects of water- soluble contrast agents on rat hippocampus. Invest Radiol19: 192–201, 1984.
26.
HoltasSCronquistSRenaaT: Contrast enhanced brain CT. Comparison between Iohexol and Metrizoate. Invest Radio20 (Suppl. 1) January/February 1985.
27.
JunkLMarshallWH: Neurotoxicity of radiological contrast agents. Ann Neurol13: 469–484, 1983.
28.
KatayamaHTanakaT: Clinical survey of adverse reactions of contrast media in Japan. Contrast Media1987, World Symposium, may 25–29 1987. Montbazon, France (soumis à publication in Invest Radiol).
29.
KivisaariLBeanPBKormanoM: Contrast enhancement pharmacocikinetics of ionic and nonionic contrast agents. In: Contrast Media in Radiology, AmielM, Springer-Verlag, Berlin, Heidelberg, New York, 1982; 324–326.
30.
KormanoMSpataroRF:: Comparison of contrast enhancement pharmacokinetics of contrast media in clinical patients. In: Contrast Media in Radiology, AmielM, Springer-Verlag, Berlin, Heidelberg, New York, 1982;314–318.
31.
LaerumF: Acute damage to human endothelial cells by brief exposure to contrast media in vitro. Radiology147: 681–684, 1983.
32.
LambJT: Iohexol vs. Iopamidol for myelography. Invest Radiol20 (Suppl. 1): 537–543, 1985.
33.
LasserEC: Etiology of anaphylactoid responses. The promise of nonionics. Invest Radiol, 20 (Suppl. 1) January/February, 1985.
34.
PajanenH: The effect of Ionic and Nonionic contrast media on the metabolism of prostaglandin E2 in rat lungs. Invest Radiol19: 216–220, 1984.
PicardLMoretC: Intérêt de l'Iopamidol en tomodensitométrie encéphalique. Etude expérimentale. Ann Radiol26: 807–808, 1983.
37.
SageMR: Kinetics of water-soluble contrast media in the central nervous system. AJNR141: 815–824, 1983.
38.
SimonJHEkholmSE: Further support for the glucose hypothesis of metrizamide toxicity: the effect of metrizamide and glucose analogue-free contrast media of hexokinase. Invest Radiol22: 137–140, 1987.
39.
SovakMRanganathanR: Stability of nonionic- water-soluble contrast media: Implications of their design. Invest Radiol15: 323–328, 1980.
40.
SovakM: Radiographic contrast media (CM) in Neuroradiology. State of the art. Radiol Med72 (Suppl. 2) 6–9, 1986.
41.
SteinerRMGraingerRG: The effect of contrast media of low osmolarity on the peripheral arterial blood flow in the dog. Clin Radiol31: 621–627, 1980.
42.
WilminkJTRoukemaJG: Effects of IV contrast administration on intraspinal and paraspinal tissues: a CT study. 1. Measurement. AJNR8: 703–709, 1987.